On May 26, 2022, the Oregon Health Authority (OHA) announced it received a legal memorandum from the Oregon Department of Justice (ODOJ). The legal memorandum (memo) addresses the Oregon Psilocybin Services Program and discussed the Entheogenic Framework. The Entheogenic Framework is a document created by Jon Dennis, an attorney in Oregon. It is a set
We often receive questions from ketamine clinics regarding who must obtain a DEA registration to dispense controlled substances. There are two candidates to consider – the healthcare providers who work at the clinic and the clinic itself. Often, there is a misconception about whether a clinic needs to hold a DEA registration. We wrote about
The Oregon Psilocybin Advisory Board (OPAB) was established by Measure 109 and is responsible for making recommendations to the Oregon Health Authority (OHA) for psilocybin services in Oregon. OPAB has met monthly since March of 2021, and the last monthly meeting is set for June 22, 2022. After that, OPAB will meet every two months.
Florida Rep. Michael Grieco’s decision not to seek a new legislative term could negatively impact efforts to advance the legal use of psychedelics in the Sunshine State. The representative has been the most vocal advocate for psychedelics reform in the Florida Legislature. In 2021, Grieco filed a bill (HB 549) that would have legalized the
Oregon psilocybin service centers will be open for business after the Oregon Health Authority (OHA) finalizes regulations and issues licenses early next year. Psilocybin services will be heavily regulated, and business owners are encouraged to pay close attention to OHA rules. But unexpected issues may arise that are unrelated to OHA. For instance, the legal
The cannabis industry is evolving rapidly across North America and beyond, and the psychedelics revolution is well underway. As a result, there is a growing disparity among laws of different jurisdictions. Businesses involved in cannabis production and sales, such as growers, distributors, importers, and producers, face an array of legal challenges, including regulatory compliance, taxation,
Psilocybin, synesthesia and informed consent. What a mashup! When a person can hear the color “blue,” or taste the word “apple,” can that person legally give consent? What if a client requests a facilitator to give a reassuring touch during an administration session, but later sues the facilitator for unwanted physical contact? Oregon is in
Welcome to the fourth installment in this series surveying business and regulatory issues in the Oregon psilocybin program. Today I’ll cover access to professional service providers. Service providers and the Oregon psilocybin industry I’ve mentioned before that Oregon psilocybin shares many parallels with what came before with cannabis. In the early days of cannabis, it
Regulations continue to develop in Oregon for psilocybin services, and businesses will soon operate in the new industry. As we explained in a recent webinar, the new industry will be heavily regulated, and psilocybin-related businesses will be expected to strictly comply with these regulations and the Oregon Psilocybin Services Act. These businesses will need help
Federal law requires prior in-person evaluations before a physician can provide telehealth services. The federal government declared a COVID-19 public health emergency, essentially suspending this rule. Following this suspension, ketamine telehealth providers and other virtual telehealth providers popped up all over the country. In all likelihood, the emergency declaration will end soon, leaving the industry
